Literature DB >> 33208692

Liver Transplantation in Acute-on-chronic Liver Failure.

Constantine J Karvellas1, Claire Francoz, Emmanuel Weiss.   

Abstract

Liver transplantation (LT) has revolutionized outcomes for cirrhotic patients. Current liver allocation policies dictate patients with highest short-term mortality receive the highest priority, thus, several patients become increasingly ill on the waitlist. Given cirrhosis is a progressive disease, it can be complicated by the occurrence of acute-on-chronic liver failure (ACLF), a syndrome defined by an acute deterioration of liver function associated with extrahepatic organ failures requiring intensive care support and a high short-term mortality. Successfully bridging to transplant includes accurate prognostication and prioritization of ACLF patients awaiting LT, optimizing intensive care support pre-LT, and tailoring immunosuppressive and anti-infective therapies post-LT. Furthermore, predicting futility (too sick to undergo LT) in ACLF is challenging. In this review, we summarize the role of LT in ACLF specifically highlighting (a) current prognostic scores in ACLF, (b) critical care management of the ACLF patient awaiting LT, (c) donor issues to consider in transplant in ACLF, and (d) exploring of recent post-LT outcomes in ACLF and potential opportunities to improve outcomes including current care gaps and unmet research needs.
Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Year:  2021        PMID: 33208692     DOI: 10.1097/TP.0000000000003550

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  7 in total

1.  Transplantation for EASL-CLIF and APASL acute-on-chronic liver failure (ACLF) patients: The TEA cohort to evaluate long-term post-Transplant outcomes.

Authors:  Lei Xia; Zi-Yun Qiao; Zi-Jie Zhang; Zi-Cheng Lv; Huan Tong; Ying Tong; Hao-Xiang Wu; Xiao-Song Chen; Han-Yong Sun; Jian-Jun Zhang; Wolfgang Ervin Thasler; Hao Feng; Qiang Xia
Journal:  EClinicalMedicine       Date:  2022-06-04

2.  Improved Survival With Higher-risk Donor Grafts in Liver Transplant With Acute-on-chronic Liver Failure.

Authors:  Toshihiro Kitajima; Yasutaka Kuno; Tommy Ivanics; Mei Lu; Dilip Moonka; Shingo Shimada; Tayseer Shamaa; Marwan S Abouljoud; Shunji Nagai
Journal:  Transplant Direct       Date:  2022-01-26

3.  Severe Alcohol-Associated Hepatitis Is Associated With Worse Survival in Critically Ill Patients With Acute on Chronic Liver Failure.

Authors:  Kavish R Patidar; Jennifer L Peng; Harleen Kaur; Astin Worden; Carla D Kettler; Francis Pike; Caitriona A Buckley; Eric S Orman; Archita P Desai; Lauren D Nephew; Chandrashekhar A Kubal; Samer Gawrieh; Naga Chalasani; Marwan S Ghabril
Journal:  Hepatol Commun       Date:  2021-12-03

4.  Serum Nitric Oxide Level Serves as a Potential Prognostic Biomarker in ACLF Patients.

Authors:  Fei Wang; Minghui Tai; Yajuan He; Zhen Tian
Journal:  Int J Gen Med       Date:  2022-08-22

5.  G-CSF promotes the viability and angiogenesis of injured liver via direct effects on the liver cells.

Authors:  Zifeng Liu; Guiling Zhang; Jing Chen; Jingjing Tong; Hongmin Wang; Jing Chen; Dong Yang; Jinhua Hu
Journal:  Mol Biol Rep       Date:  2022-07-04       Impact factor: 2.742

Review 6.  Applications of human organoids in the personalized treatment for digestive diseases.

Authors:  Qinying Wang; Fanying Guo; Yutao Jin; Yanlei Ma
Journal:  Signal Transduct Target Ther       Date:  2022-09-27

7.  Identification of effective diagnostic biomarker and immune cell infiltration characteristics in acute liver failure by integrating bioinformatics analysis and machine-learning strategies.

Authors:  Mengqin Yuan; Lichao Yao; Xue Hu; Yingan Jiang; Lanjuan Li
Journal:  Front Genet       Date:  2022-09-28       Impact factor: 4.772

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.